Abbonarsi

Improved myocardial scar visualization using free-breathing motion-corrected wideband black-blood late gadolinium enhancement imaging in patients with implantable cardiac devices - 06/05/25

Doi : 10.1016/j.diii.2024.12.001 
Pauline Gut a, b, c, Hubert Cochet d, Panagiotis Antiochos e, Guido Caluori a, Baptiste Durand a, Marion Constantin a, Konstantinos Vlachos a, Kalvin Narceau a, Ambra Masi e, Jürg Schwitter c, e, Frederic Sacher a, f, Pierre Jaïs a, f, Matthias Stuber a, b, g, Aurélien Bustin a, b, d,
a IHU LIRYC, Heart Rhythm Disease Institute, Université de Bordeaux, INSERM U1045, 33604, Pessac, France 
b Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland 
c Faculty of Biology and Medicine, University of Lausanne, 1011 Lausanne, Switzerland 
d Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33604 Pessac, France 
e Cardiovascular Department, Division of Cardiology, University Hospital of Lausanne and University of Lausanne, 1011 Lausanne, Switzerland 
f Department of Cardiac Pacing and Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33604 Pessac, France 
g CIBM Center for Biomedical Imaging, 1011 Lausanne, Switzerland 

Corresponding author.

Highlights

Free-breathing wideband black-blood late gadolinium enhancement cardiac MR images are reconstructed in <2 s.
Non-rigid motion reconstruction enables motion-free black-blood late gadolinium enhancement cardiac MR imaging.
Free-breathing wideband black-blood late gadolinium enhancement MR imaging enables improved detection of myocardial scar and suppression of artifacts in the myocardium associated with implantable cardiac devices.

Il testo completo di questo articolo è disponibile in PDF.

ABSTRACT

Purpose

The purpose of this study was to introduce and evaluate a novel 2D wideband black-blood (BB) LGE sequence, incorporating wideband inversion recovery, wideband T2 preparation, and non-rigid motion correction (MOCO) reconstruction, to improve myocardial scar detection and address artifacts associated with implantable cardioverter defibrillators (ICDs).

Materials and methods

The wideband MOCO free-breathing BB-LGE sequence was tested on a sheep with ischemic scar and in 22 patients with cardiac disease, including 15 with cardiac implants, at 1.5T. Wideband MOCO free-breathing BB-LGE sequence was compared with conventional and wideband breath-held PSIR-LGE and conventional and wideband breath-held BB-LGE techniques. Image sharpness, entropy, and scar-to-blood, scar-to-myocardium, and blood-to-myocardium contrast were analyzed and reconstruction times were measured. Two expert readers assessed the image quality, ICD artifact severity, and the diagnostic confidence with scar extent. Finally, for the animal study, a histology of the heart was performed to confirm the presence and localization of scar tissue.

Results

In the animal, wideband MOCO free-breathing BB-LGE were reconstructed in 0.6 s and demonstrated a 200 % improvement in scar-to-blood contrast compared to wideband breath-held PSIR-LGE, with significant improvement in image sharpness and reduction in entropy. It also effectively minimized ICD artifacts and accurately detected scars. In patients, wideband MOCO free-breathing BB-LGE were reconstructed in 1.5 ± 0.4 (standard deviation) s per slice. Seventeen patients (17/22; 77%) with myocardial scars were confidently diagnosed with wideband MOCO free-breathing BB-LGE, compared to 11 (11/22; 50 %) with wideband breath-held PSIR-LGE (P < 0.01).

Conclusion

Free-breathing wideband T2-prepared black-blood LGE imaging, combined with motion-corrected reconstruction, offers a promising diagnostic approach for the evaluation of myocardial lesions in patients with ICDs.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Black blood imaging, Implantable cardioverter defibrillator, Cardiac magnetic resonance imaging, Motion artifacts, Myocardial infarction

Abbreviations : 2D, AHA, BB, BW, CI, CIED, CMR, CRT-D, GRAPPA, GRE, ICD, IR, LGE, LVEF, MOCO, MRI, N/A, NYHA, PSIR, Q1, Q3, RVEF, S-ICD, SA, SCA, SD, T2prep, TI, TV- ICD, VT


Mappa


© 2024  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 106 - N° 5

P. 169-182 - maggio 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Evaluation of navigation and robotic systems for percutaneous image-guided interventions: A novel metric for advanced imaging and artificial intelligence integration
  • Francois H. Cornelis, Dimitrios K Filippiadis, Philipp Wiggermann, Stephen B. Solomon, David C. Madoff, Laurent Milot, Sylvain Bodard
| Articolo seguente Articolo seguente
  • Real-time multislice MR-thermometry of the prostate: Assessment of feasibility, accuracy and sources of biases in patients
  • Clément Marcelin, Amandine Crombé, Eva Jambon, Grégoire Robert, Franck Bladou, Pierre Bour, Thibaut Faller, Valéry Ozenne, Nicolas Grenier, Bruno Quesson

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.